Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Selectis Health (GBCS) Debt to Equity (2017 - 2025)

Selectis Health's Debt to Equity history spans 12 years, with the latest figure at -$4.98 for Q4 2025.

  • Quarterly results put Debt to Equity at -$4.98 for Q4 2025, down 119.79% from a year ago — trailing twelve months through Dec 2025 was -$4.98 (down 119.79% YoY), and the annual figure for FY2025 was -$4.98, down 119.79%.
  • Debt to Equity for Q4 2025 was -$4.98 at Selectis Health, up from -$5.36 in the prior quarter.
  • In the past five years, Debt to Equity ranged from a high of $53.27 in Q3 2023 to a low of -$12.26 in Q4 2023.
  • The 5-year median for Debt to Equity is $3.68 (2022), against an average of $6.09.
  • The sharpest move saw Debt to Equity skyrocketed 5945.65% in 2023, then tumbled 219.78% in 2024.
  • Year by year, Debt to Equity stood at $12.05 in 2021, then soared by 219.71% to $38.51 in 2022, then plummeted by 131.84% to -$12.26 in 2023, then skyrocketed by 81.54% to -$2.26 in 2024, then tumbled by 119.79% to -$4.98 in 2025.
  • According to Business Quant data, Debt to Equity over the past three periods came in at -$4.98, -$5.36, and -$4.69 for Q4 2025, Q3 2025, and Q2 2025 respectively.